| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/19/2005 | EP1070081A4 Novel molecules of the t129-related protein family and uses thereof |
| 01/19/2005 | EP1034298A4 Humanization of murine antibody |
| 01/19/2005 | EP0888461A4 Tissue remodeling proteins |
| 01/19/2005 | EP0821737A4 NUCLEOTIDE SEQUENCE OF THE HAEMOPHILUS INFLUENZAE Rd GENOME, FRAGMENTS THEREOF, AND USES THEREOF |
| 01/19/2005 | EP0545946B1 Growth-promoting agent |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
| 01/19/2005 | CN1568193A Use of il-18 inhibitors in hypersensitivity disorders |
| 01/19/2005 | CN1566342A Antigenic epitope of S-protein of SARS coronavirus, antibody of S-protein of SARS coronavirus , nucleic acid encoding S-protein of SARS coronavirus and compositions containing same |
| 01/19/2005 | CN1566334A Novel reovirus, its antibody and vaccine and use thereof |
| 01/19/2005 | CN1566155A Anti-SARS monoclonal antibody, encoding sequence and application thereof |
| 01/19/2005 | CN1566150A Human amyloid precursor protein 639, coded sequence and uses thereof |
| 01/19/2005 | CN1566149A Immunosuppressive receptor derived from dendritic cell, coded sequence and uses thereof |
| 01/19/2005 | CN1566148A Tumor suppressor, coded protein and application thereof |
| 01/19/2005 | CN1566143A Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 01/19/2005 | CN1565628A Usage of reovirus genome and its coding protein in the SARS related research |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185255C Compositions and Methods for detecting treponema pallidum |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844193 Detecting ligand for fibroblast growth factor binding protein; obtain nucleotide sequence libraries, obtain cells, transform cell with nucleotide sequences, monitor kinase activity, amplified activity indicates presence of ligand |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844181 Method of inhibiting fungal growth |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844164 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 01/18/2005 | US6844162 Identifying imunoglobulins associated with thyroid stimulating hormone receptor (TRAB) for diagnosing and treating graves' and glandular disorders |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6843999 Streptococcal ABC transporter protein |
| 01/18/2005 | US6843990 Monoclonal antibodies for the detection of decoy receptor 3, hybridomas producing said antibodies and uses thereof |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/18/2005 | CA2074556C Immunological detection method |
| 01/13/2005 | WO2005003782A1 Secreted polypeptide species reduced in cardiovascular disorders |
| 01/13/2005 | WO2005003775A2 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/13/2005 | WO2005003764A2 Assay for detecting atrial and brain natriuretic peptide prohormones |
| 01/13/2005 | WO2005003345A2 Look-through mutagenesis |
| 01/13/2005 | WO2005003325A2 Inhibition of viral pathogenesis |
| 01/13/2005 | WO2005003302A2 Novel methods to modulate mast cells |
| 01/13/2005 | WO2005003298A2 Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease |
| 01/13/2005 | WO2005003176A1 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 01/13/2005 | WO2005003175A2 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 01/13/2005 | WO2005003174A1 BINDING MEMBER TOWARDS PNEUMOCOCCUS SURFACE ADHESIN A PROTEIN (PsaA) |
| 01/13/2005 | WO2005003173A1 Process of obtaining a freeze-dried complex from mammal gland secretion |
| 01/13/2005 | WO2005003172A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | WO2005003171A2 Modified antibody fragments |
| 01/13/2005 | WO2005003170A2 Modified antibody fragments |
| 01/13/2005 | WO2005003169A2 Modified antibody fab fragments |
| 01/13/2005 | WO2005003168A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 01/13/2005 | WO2005003158A2 Compositions and methods for increasing bone mineralization |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005002529A2 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/13/2005 | WO2005002527A2 Sirt1 modulation of adipogenesis and adipose function |
| 01/13/2005 | WO2005002513A2 C1q complement inhibitors and methods of use thereof |
| 01/13/2005 | WO2005002511A2 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | WO2004080375A3 Vaccine therapy of atherosclerosis |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004050017A3 Rationally designed antibodies |
| 01/13/2005 | WO2004035003A3 Therapeutic adjuvant |
| 01/13/2005 | WO2004031230A3 Novel mhc ii associated peptides |
| 01/13/2005 | WO2004031209A3 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 01/13/2005 | WO2004027381A3 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003072715A8 Gasp1: a follistatin domain containing protein |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009769 Means for use in diagnostics and/or therapy |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009145 Mammalian receptor proteins; related reagents and methods |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009136 Pregnancy-associated plasma protein-A (PAPP-A) ligand for use as tool in identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 01/13/2005 | US20050009110 Identifying and rasing monoclonal antibodies specific to endothelial growth factors for use in the treatment and detection infection, autoimmune and cell proliferative disorders |
| 01/13/2005 | US20050009108 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 01/13/2005 | US20050009097 Immunoglobulin specific to epithelial cell adhesion molecule (Ep-CAM) for use in disgnosis and treatment of cell proliferative disorders; immunotherapy |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050009037 Helicobacter bizzozeronii outer membrane protein encoding gene and its use in diagnostic and treatment methods |
| 01/13/2005 | US20050009024 Using allelic variance in carboxypeptidase gene as diagnostic indicator of cardiovascular disease |
| 01/13/2005 | US20050009021 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 01/13/2005 | US20050009009 Diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 01/13/2005 | US20050008658 Enterococcus antigens and vaccines |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008649 Endostatin fused to antibody as antitumor agents; stability |
| 01/13/2005 | US20050008648 Mutant kinase; anticancer agents; supplying to leukemia blastocytes; antibody which detects cell surface antigen; antiproliferative agent |
| 01/13/2005 | US20050008647 Induction antiidiotype antibodies |
| 01/13/2005 | US20050008646 Screening fir cytotoxic end points; cancerous disease modifying antibodies |
| 01/13/2005 | US20050008645 Antibodies Specific For Phosphatase Subunit of LAR |
| 01/13/2005 | US20050008643 Diagnostic methods and agents |
| 01/13/2005 | US20050008642 Antibodies against insulin-like growth factor 1 receptor and uses thereof |
| 01/13/2005 | US20050008641 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| 01/13/2005 | US20050008639 Methods of modulating homing of T cell by interruption of chemokine/chemokine receptor signaling |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | US20050008627 Administering tumor necrosis factor directly to lungs; asthma therapy; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050008625 Antibody affinity engineering by serial epitope-guided complementarity replacement |